Sun Pharma Falls Most in Two Months After Profit Misses Views

Sun Pharmaceutical Industries Ltd., India's largest drugmaker, fell the most in two months after reporting fourth-quarter earnings that missed analyst estimates amid higher investments and regulatory pressures. The stock fell as much as 4.6 percent to 775 rupees, the biggest drop since March 29 on an intra-day basis.

Sun Pharma Says U.S. Unit Gets Subpoena in Antitrust Probe

Sun Pharmaceutical Industries Ltd., India's largest drugmaker, said its U.S. unit received a grand jury subpoena from the Justice Department's antitrust division related to generic products and pricing. The summons also sought documents about communications with competitors and others regarding the sale of generic drugs, along with corporate and employee records, Sun Pharma said in a May 27 stock exchange filing.